Skip to main content Skip to main navigation
Rijksoverheid logo | to homepage of RIVM National Institute for Public Health and the Environment Ministry of Health, Welfare and Sport
  • Nederlands
  • English
RIVM Committed to health and sustainability
  • Home
  • Topics
  • About RIVM
  • Publications
  • International
  • Contact
  • Agenda
  • MijnRIVM
  • Nederlands
  • English
  • Home
  • Search

Search

Skip searchoptions

Search

Fill in your search phrase.

Type

Selecting an option will change the focus to the start of the list.
  • News item (16)
  • Page (11)
  • Blog post (5)
  • Subject (2)
  • Single page (1)

Publication date

Selecting an option will change the focus to the start of the list.
  • (-) June 2026 (21)
  • (-) April 2021 (15)
  • August 2026 (3)
  • July 2026 (13)
  • May 2026 (14)
  • April 2026 (11)
  • March 2026 (19)
  • February 2026 (8)
  • January 2026 (10)
  • December 2025 (21)
  • November 2025 (16)
  • October 2025 (11)
  • September 2025 (19)
  • August 2025 (9)
  • July 2025 (7)
  • June 2025 (8)
  • May 2025 (4)
  • April 2025 (9)
  • March 2025 (3)
  • February 2025 (6)
  • January 2025 (21)
  • December 2024 (13)
  • November 2024 (7)
  • October 2024 (10)
  • September 2024 (7)
  • August 2024 (5)
  • July 2024 (12)
  • June 2024 (7)
  • May 2024 (9)
  • April 2024 (20)
  • March 2024 (10)
  • February 2024 (7)
  • January 2024 (3)
  • December 2023 (15)
  • November 2023 (6)
  • October 2023 (10)
  • September 2023 (17)
  • August 2023 (4)
  • July 2023 (13)
  • June 2023 (17)
  • May 2023 (4)
  • April 2023 (15)
  • March 2023 (20)
  • February 2023 (20)
  • January 2023 (10)
  • December 2022 (14)
  • November 2022 (25)
  • October 2022 (18)
  • September 2022 (10)
  • August 2022 (11)
  • July 2022 (18)
  • June 2022 (18)
  • May 2022 (10)
  • April 2022 (6)
  • March 2022 (9)
  • February 2022 (7)
  • January 2022 (4)
  • December 2021 (17)
  • November 2021 (9)
  • October 2021 (9)
  • September 2021 (9)
  • August 2021 (6)
  • July 2021 (18)
  • June 2021 (14)
  • May 2021 (15)
  • March 2021 (12)
  • February 2021 (12)
  • January 2021 (7)
  • December 2020 (11)
  • November 2020 (5)
  • October 2020 (9)
  • September 2020 (2)
  • August 2020 (1)
  • July 2020 (4)
  • June 2020 (9)
  • May 2020 (10)
  • April 2020 (10)
  • March 2020 (8)
  • February 2020 (10)
  • January 2020 (6)
  • December 2019 (4)
  • November 2019 (5)
  • October 2019 (11)
  • September 2019 (4)
  • August 2019 (12)
  • July 2019 (4)
  • June 2019 (9)
  • May 2019 (13)
  • April 2019 (8)
  • March 2019 (5)
  • February 2019 (9)
  • January 2019 (10)
  • December 2018 (5)
  • November 2018 (13)
  • October 2018 (12)
  • September 2018 (2)
  • August 2018 (5)
  • July 2018 (6)
  • May 2018 (4)
  • April 2018 (1)
  • March 2018 (5)
  • February 2018 (4)
  • January 2018 (2)
  • December 2017 (12)
  • November 2017 (2)
  • October 2017 (6)
  • September 2017 (12)
  • August 2017 (7)
  • July 2017 (5)
  • June 2017 (1)
  • May 2017 (2)
  • April 2017 (2)
  • March 2017 (4)
  • February 2017 (3)
  • January 2017 (4)
  • December 2016 (8)
  • November 2016 (2)
  • October 2016 (7)
  • August 2016 (1)
  • July 2016 (1)
  • June 2016 (2)
  • March 2016 (15)
  • February 2016 (1)
  • January 2016 (6)
  • December 2015 (7)
  • November 2015 (5)
  • October 2015 (2)
  • August 2015 (1)
  • July 2015 (7)
  • June 2015 (2)
  • May 2015 (1)
  • April 2015 (5)
  • March 2015 (14)
  • February 2015 (3)
  • January 2015 (1)
  • October 2014 (3)
  • August 2014 (3)
  • July 2014 (1)
  • June 2014 (4)
  • May 2014 (1)
  • April 2014 (7)
  • March 2014 (3)
  • February 2014 (10)
  • December 2013 (9)
  • November 2013 (3)
  • October 2013 (1)
  • September 2013 (2)
  • August 2013 (2)
  • July 2013 (2)
  • May 2013 (1)
  • March 2013 (2)
  • December 2012 (1)
  • November 2012 (5)
  • October 2012 (2)
  • July 2012 (5)
  • April 2012 (2)
  • March 2012 (1)
  • February 2012 (8)
  • January 2012 (11)
  • December 2011 (8)
  • September 2011 (6)
  • June 2011 (1)
  • May 2011 (1)
  • March 2011 (2)
  • January 2011 (1)

Topics

Selecting an option will change the focus to the start of the list.
  • International (10)
  • Nanotechnology and advanced materials (5)
  • COVID-19 (4)
  • Inhalation toxicology (2)
  • Medicinal products (2)
  • Public Health Foresight (2)
  • Food and Nutrition (1)
  • Hantavirus (1)
  • Heat (1)
  • Sexually transmitted infections (STIs) (1)

36 search results

You searched for these word(s): risk assessment
  • Global Risk Assessment of Public Health in the Netherlands (GRASPH)

    https://www.rivm.nl/en/public-health-foresight/grasph

    … both now and in the future. To be better prepared for these risks, RIVM assessed the most important health risks to the Netherlands.   …   Key risks for the next decade include antimicrobial resistance, … and government, and lower willingness to vaccinate. These risks should be considered both separately and together. …

    Publication date: 06-15-2026
  • Information on Functionality can be used for Early Safety Assessment of Advanced Materials

    https://www.rivm.nl/en/weblog/information-on-functionality-can-be-used-for-early-safety-assessment-of-advanced-materials

    … by linking their designed properties to potential safety risks during early development. This approach seeks to … humans and the environment. The promise and potential risks of advanced materials Advanced materials, such as … and toxicity. Linking material properties to safety risks Using literature evidence and expert judgment, the …

    Publication date: 06-02-2026
  • Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon

    https://www.rivm.nl/en/news/children-aged-16-18-years-at-higher-risk-for-medical-reasons-will-receive-first-vaccination

    … born in 2003, 2004 and 2005 who are in the medical high-risk group. The first young people in this group will be … These young people are included in the medical high-risk group that the Health Council has defined for adults. … Children aged 16-18 years at higher risk for medical reasons will receive first vaccination soon …

    Publication date: 04-19-2021
  • People with a medical risk between the ages of 18-60 years invited from early May on

    https://www.rivm.nl/en/news/people-with-medical-risk-between-ages-of-18-60-years-invited-from-early-may-on

    … in the first week of May, people under 60 who are at risk for medical reasons, i.e. the group eligible for the … in this group are prioritised because they have a higher risk of severe illness from COVID-19. This includes people … to respiratory tract infections. People in the medical high-risk groups already received their invitations for COVID-19 …

    Publication date: 04-20-2021
  • Clean Air Agreement: Better air quality in 2030 for greater health gains

    https://www.rivm.nl/en/news/clean-air-agreement-better-air-quality-in-2030-for-greater-health-gains

    … Institute for Public Health and the Environment (RIVM) assesses the health impacts of the plans under the Clean Air … Lucht Akkoord, SLA). According to the third progress assessment, health gains from cleaner air in 2030 will be … expected to be approximately 8% lower than under the former assessment. Provided that all policy plans are implemented, …

    Publication date: 06-16-2026
  • New hold on vaccination with AstraZeneca for people under 60 years

    https://www.rivm.nl/en/news/new-hold-on-vaccination-with-astrazeneca-for-people-under-60-years

    … Pharmacovigilance Centre Lareb. The EMA’s Pharmacovigilance Risk Assessment Committee (PRAC) is currently investigating this … the investigation are expected on Wednesday, 7 April. A new assessment about the use of AstraZeneca will be made at that … in 1961 or later. For people aged 60 or over, the health risk from contracting COVID-19 is much higher than the risk …

    Publication date: 04-02-2021
  • Testing for the Andes virus

    https://www.rivm.nl/en/hantavirus/andes-virus/testing-for-andes-virus

    … helps prevent the possible further spread of the virus. The risk that the virus will continue to spread among the … is infected with the Andes virus. After six weeks, the risk of someone still testing positive is very low. That is …

    Publication date: 06-03-2026
  • Ongoing decline in the number of STI consultations in 2025, number of gonorrhoea and syphilis diagnoses remains persistently high

    https://www.rivm.nl/en/news/ongoing-decline-in-number-of-sti-consultations-in-2025-number-of-gonorrhoea-and-syphilis

    … 2024. SHCs offer free testing to people who have a higher risk of STIs and who experience barriers to visiting a GP. …

    Publication date: 06-25-2026
  • Newsletter on COVID-19 vaccination issue 12 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/12

    … Vaccination starts for medical high risk groups … for elderly people and for people in the medical high-risk group due to neurological disorders accompanied by … has been made for four categories in the the medical high-risk groups . This applies to people whose immune system is …

    Publication date: 04-02-2021
  • What RIVM does

    https://www.rivm.nl/en/inhalation-toxicology/what-rivm-does

    … the government on the potential harmfulness, or health risks, of airborne substances. Thanks to this research, RIVM … This knowledge base is essential to be able to assess the risks. Advice RIVM advises ministries on the risks of … are working together to define guidelines for health risk assessments. RIVM also contributes to OECD documents used to …

    Publication date: 06-03-2026
  • EU Commission prepares Advanced Materials Act to drive innovation and strengthen competitiveness

    https://www.rivm.nl/en/weblog/eu-commission-prepares-advanced-materials-act-to-drive-innovation-and-strengthen

    … current regulations and test methods may not adequately assess advanced materials, calling for a robust risk governance system embedded in the EU innovation … and the need for appropriate, harmonised test methods to assess safety. Public authorities also referred to existing …

    Publication date: 06-02-2026
  • Different vaccine very soon available to people under 60, instead of AstraZeneca

    https://www.rivm.nl/en/news/different-vaccine-very-soon-available-to-people-under-60-instead-of-astrazeneca

    … impact on five groups. This involves people at higher risk for medical reasons who are unable to travel, people … People at higher risk for medical reasons who are unable to travel  This …

    Publication date: 04-13-2021
  • Newsletter on COVID-19 vaccination issue 15, 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/15

    … born in 2003, 2004 and 2005 who are in a medical high-risk group . The first young people in this group will soon … in the first week of May, people under 60 who are at risk for medical reasons , i.e. the group eligible for the … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines …

    Publication date: 04-22-2021
  • Advanced materials and SSbD: why stronger coordination is now needed

    https://www.rivm.nl/en/weblog/advanced-materials-and-ssbd-why-stronger-coordination-is-now-needed

    … existing methods and tools for hazard, exposure, fate and risk assessment. In addition, the OECD has recently reviewed … integrative systems and platforms that support design, risk assessment and sustainability considerations for …

    Publication date: 06-02-2026
  • Newsletter on COVID-19 vaccination issue 14 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/14

    … 60 has a direct impact on five groups: people at higher risk for medical reasons who are unable to travel, people … can be attributed to the vaccine. The Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency … in 2003, 2004 and 2005) who are in one of the medical high-risk groups . This vaccine has been approved for people aged …

    Publication date: 04-20-2021
  • Inhalation toxicology publications

    https://www.rivm.nl/en/inhalation-toxicology/publications

    … the dichloro-dihydro-fluorescein (DCFH) assay for the assessment of intracellular reactive oxygen species … Importance of Variations in In Vitro Dosimetry to Support Risk Assessment of Inhaled Toxicants In Vitro Assessment of …

    Publication date: 06-03-2026
  • Newsletter on COVID-19 vaccination issue 13 2021

    https://www.rivm.nl/en/covid-19-vaccination/professionals/newsletter/2021/13

    … This was the conclusion reached by the Pharmacovigilance Risk Assessment Committee (PRAC) of the European Medicines Agency …

    Publication date: 04-12-2021
  • Global Risk Assessment for Public Health in the Netherlands | factsheet

    https://www.rivm.nl/en/documenten/global-risk-assessment-for-public-health-in-netherlands

    … This risk assessment maps out the international threats that could … to be better prepared for these threats. See also:  Global Risk Assessment for Public Health in the Netherlands (GRASPH) … Global Risk Assessment for Public Health in the Netherlands | factsheet …

    Publication date: 06-30-2026
  • Inhalation toxicology

    https://www.rivm.nl/en/inhalation-toxicology

    … is the ability to bring together scientific research, risk assessments to determine the likelihood of harmful effects …

    Publication date: 06-03-2026
  • New research methods

    https://www.rivm.nl/en/medicinal-products/new-research-methods

    … Inclusion into guidelines In order to be used in the safety assessment of medicinal products, new research methods must … Landscape for New Approach Methodologies (NAMs) for safety assessment of pharmaceutical products. Understanding these … projects to develop new research methods for the safety assessment of chemicals and medicines, such as within Ombion …

    Publication date: 06-24-2026

Pagination

  • Current page 1
  • Page 2
  • › Next
  • » Last

Service

  • Contact
  • Information for the press
  • Working for RIVM
  • Complaints
  • Submitting WOO requests to RIVM
  • Doing business with RIVM
  • Social media house rules

About this site

  • Cookies
  • Privacy
  • Accessibility
  • Disclaimer and copyright
  • Coordinated Vulnerability Disclosure
  • Website archive

Languages

  • English
  • Nederlands

Follow us

  • RIVM Newsletters
  • RSS feed
  • X Twitter
  • Facebook
  • LinkedIn
  • Youtube
  • Instagram
  • Mastodon